Today we’re going to bring you an inside look into an Italian pharmaceutical firm with over 135 years of history. 

Founded in 1886 in Naples under the name of Farmacia Internazionale, our guest for today is from Menarini Group, a leading pharmaceutical and diagnostics company with a presence in over 140 countries. 

The firm prides itself as a leading provider of important healthcare brands, with its 18 manufacturing plants producing over 609 million packets of products a year. 

To this end, Menarini said it operates across the entire commercial value chain, from clinical development, regulatory approval and product launch to lifecycle management with a diverse portfolio of proprietary and partnered brands in key therapeutic fields. 

That includes Consumer Health, Dermatology, Allergy or Respiratory, Gastroenterology, Cardio-metabolic, Anti-infectives, Oncology or Specialty Care and more.

All in, Menarini reported consolidated turnover of 4.375 billion euros in 2023, with international markets contributing 79% to the numbers. But how much of this is contributed by demand from the Asia-Pacific region? 

Meanwhile, Menarini is also seeing a number of interesting developments of late. For one thing, Menarini APAC had in June 2024 expanded its partnership with Pharmacosmos to tackle iron deficiency in patients in Singapore and Malaysia. 

So just how important are such licensing deals and partnerships in helping Menarini broaden its offerings while lowering R&D costs?

On Under the Radar, Money Matters’ finance presenter Chua Tian Tian posed these questions to Glen Godresse, CEO, Menarini APAC.

Today we&rsquo;re going to bring you an inside look into an Italian pharmaceutical firm with over 135 years of history.&nbsp;
Founded in 1886 in Naples under the name of Farmacia Internazionale, our guest for today is from Menarini Group, a leading pharmaceutical and diagnostics company with a presence in over 140 countries.&nbsp;
The firm prides itself as a leading provider of important healthcare brands, with its 18 manufacturing plants producing over 609 million packets of products a year.&nbsp;
To this end, Menarini said it operates across the entire commercial value chain, from clinical development, regulatory approval and product launch to lifecycle management with a diverse portfolio of proprietary and partnered brands in key therapeutic fields.&nbsp;
That includes Consumer Health, Dermatology, Allergy or Respiratory, Gastroenterology, Cardio-metabolic, Anti-infectives, Oncology or Specialty Care and more.
All in, Menarini reported consolidated turnover of 4.375 billion euros in 2023, with international markets contributing 79% to the numbers. But how much of this is contributed by demand from the Asia-Pacific region?&nbsp;
Meanwhile, Menarini is also seeing a number of interesting developments of late. For one thing, Menarini APAC had in June 2024 expanded its partnership with Pharmacosmos to tackle iron deficiency in patients in Singapore and Malaysia.&nbsp;
So just how important are such licensing deals and partnerships in helping Menarini broaden its offerings while lowering R&amp;D costs?
On Under the Radar, Money Matters&rsquo; finance presenter Chua Tian Tian posed these questions to Glen Godresse, CEO, Menarini APAC.

We speak with businesses, industry leaders, venture capitalists and startups on their assessment of the business environment they're in, and what the future holds for them.

We speak with businesses, industry leaders, venture capitalists and startups on their assessment of the business environment they're in, and what the future holds for them.

Under The Radar

Money Matters is your guide to navigating the day's most important topics, from politics and current affairs to wealth management and trending issues. Every evening, the team delivers insightful discussions on business news, market movements, and the latest in alternative assets. Whether navigating the political landscape, understanding the economy, or uncovering emerging investment opportunities, Money Matters keeps you informed and ahead of the curve. Tune in daily to Hongbin Jeong and Chua Tian Tian from 4 pm to 7 pm on MONEY FM 89.3.

Money Matters is your guide to navigating the day's most important topics, from politics and current affairs to wealth management and trending issues. Every evening, the team delivers insightful discussions on business news, market movements, and the latest in alternative assets. Whether navigating the political landscape, understanding the economy, or uncovering emerging investment opportunities, Money Matters keeps you informed and ahead of the curve. Tune in daily to Hongbin Jeong and Chua Tian Tian from 4 pm to 7 pm on MONEY FM 89.3.

Money Matters with Hongbin Jeong and Chua Tian Tian

MONEY FM 89.3 is Singapore’s first and only Business and Personal Finance station. MONEY FM is a 24-hour English talk format station featuring local and international business and financial news. We provide you with financial market and currency updates and insights from analysts, economists, policy makers, industry experts and business owners.

In the lighter hours, listen to discussions on social issues and features on topics that include health, education, arts and music.

MONEY FM 89.3 is Singapore&rsquo;s first and only Business and Personal Finance station. MONEY FM is a 24-hour English talk format station featuring local and international business and financial news. We provide you with financial market and currency updates and insights from analysts, economists, policy makers, industry experts and business owners.
In the lighter hours, listen to discussions on social issues and features on topics that include health, education, arts and music.

MONEY FM 89.3 is Singapore’s first and only Business and Personal Finance station.

MONEY FM 89.3

Under the Radar: What should we know about Italian pharmaceutical giant Menarini’s growth story in APAC and how important are partnerships to the firm?

Today we’re going to take you through the ins and outs of a semiconductor optics company that made the headlines for its performance post-IPO on the Singapore Exchange. 

Listed on the SGX in September 2025, our guest for today MetaOptics develops metalenses, or flat, glass-based lenses made with the same technology and process as semiconductor chips.

But what does this mean exactly? Well, lenses are typically made using curved glass, which helps them refract and focus light rays, say in the case of camera lenses or magnifying glasses.  

MetaOptics, on the other hand, uses a different process to make its lenses. Instead of using curved glasses, it uses a process called semiconductor photolithography to carve out microscopic pillars on a flat wafer, just like how transistors are engraved onto silicon chips. 

With the microscopic pillars engraved on the lenses, the lenses behave like silicon chips, where their reflective index changes when varying amounts of electricity passes through it. This means the same lens can adopt multiple properties and perform multiple tasks from zooming in, focusing, or even shifting depth, depending on the situation. 

In application, this means that devices such as smartphones, laptops or projectors will only need one metalens to perform multiple functions. This reduces the thickness and weight of hardware devices, making them easier to carry around.

Beyond that, metalens can also be used to transmit information using light. This presents an opportunity for the firm to tap the rise in demand for computing devices in the age of AI. So how does the firm define its value proposition exactly, and what are the key revenue drivers for it? 

Meanwhile, MetaOptics listed on the Catalist board of the Singapore Exchange in September 2025, and has seen its shares rise five fold in three months. More recently, the firm also announced plans to seek a dual listing on the US NASDAQ stock exchange.

So how has the firm used the additional public capital raised? What are its plans for the future and what is its assessment of the effectiveness of listing on the local bourse then?

On Under the Radar, Money Matters’ finance presenter Chua Tian Tian posed these questions to Mark Thng, CEO, Metaoptics.

Today we&rsquo;re going to take you through the ins and outs of a semiconductor optics company that made the headlines for its performance post-IPO on the Singapore Exchange.&nbsp;
Listed on the SGX in September 2025, our guest for today MetaOptics develops metalenses, or flat, glass-based lenses made with the same technology and process as semiconductor chips.
But what does this mean exactly? Well, lenses are typically made using curved glass, which helps them refract and focus light rays, say in the case of camera lenses or magnifying glasses. &nbsp;
MetaOptics, on the other hand, uses a different process to make its lenses. Instead of using curved glasses, it uses a process called semiconductor photolithography to carve out microscopic pillars on a flat wafer, just like how transistors are engraved onto silicon chips.&nbsp;
With the microscopic pillars engraved on the lenses, the lenses behave like silicon chips, where their reflective index changes when varying amounts of electricity passes through it. This means the same lens can adopt multiple properties and perform multiple tasks from zooming in, focusing, or even shifting depth, depending on the situation.&nbsp;
In application, this means that devices such as smartphones, laptops or projectors will only need one metalens to perform multiple functions. This reduces the thickness and weight of hardware devices, making them easier to carry around.
Beyond that, metalens can also be used to transmit information using light. This presents an opportunity for the firm to tap the rise in demand for computing devices in the age of AI. So how does the firm define its value proposition exactly, and what are the key revenue drivers for it?&nbsp;
Meanwhile, MetaOptics listed on the Catalist board of the Singapore Exchange in September 2025, and has seen its shares rise five fold in three months. More recently, the firm also announced plans to seek a dual listing on the US NASDAQ stock exchange.
So how has the firm used the additional public capital raised? What are its plans for the future and what is its assessment of the effectiveness of listing on the local bourse then?
On Under the Radar, Money Matters&rsquo; finance presenter Chua Tian Tian posed these questions to Mark Thng, CEO, Metaoptics.

Under the Radar: What is next for semiconductor optics firm MetaOptics post-SGX listing and how does it assess the effectiveness of listing on the local bourse? Its CEO explains.

We’re going to talk all about a hotpot ingredient that is sure to be on your reunion dinner table on Chinese New Year eve – the humble, inexpensive, yet comforting fishball that completes the meal.

Speaking of fishballs, one must talk about Thong Siek Food Global, who’s also better known as the parent company of Dodo fishballs.

Founded in 1976 as a family run backyard operation, Thong Siek Food Global has since evolved into a leading manufacturer, distributor and retailer of surimi (or minced fish paste) based seafood products in Singapore.

At its factory in Senoko spanning over 150,000 square feet, Thong Siek Global processes well over 28,000 kg of fish meat daily and more than 60 varieties of fish-based products including fishballs, prawn balls, cuttle fish balls and crab flavoured sticks.

These are exported to markets across Europe and Southeast Asia as well as the US, Canada, Dubai, Qatar, Australia and more.

But how is Thong Siek Global positioning its supply chain to grow internationally? Which are the key global markets for the firm?

Also – what are the key product trends that Thong Siek Global is tapping to relate with next generation consumers? 

In this Special, “On the Go” episode of Under the Radar, Money Matters’ finance presenter Chua Tian Tian headed down to Thong Siek Food Global’s factory floor to seek some answers from Novelle Lim, CEO of Thong Siek Global and Fayy Lim, Chief Operating Officer of Thong Siek Global.

We&rsquo;re going to talk all about a hotpot ingredient that is sure to be on your reunion dinner table on Chinese New Year eve &ndash; the humble, inexpensive, yet comforting fishball that completes the meal.
Speaking of fishballs, one must talk about Thong Siek Food Global, who&rsquo;s also better known as the parent company of Dodo fishballs.
Founded in 1976 as a family run backyard operation, Thong Siek Food Global has since evolved into a leading manufacturer, distributor and retailer of surimi (or minced fish paste) based seafood products in Singapore.
At its factory in Senoko spanning over 150,000 square feet, Thong Siek Global processes well over 28,000 kg of fish meat daily and more than 60 varieties of fish-based products including fishballs, prawn balls, cuttle fish balls and crab flavoured sticks.
These are exported to markets across Europe and Southeast Asia as well as the US, Canada, Dubai, Qatar, Australia and more.
But how is Thong Siek Global positioning its supply chain to grow internationally? Which are the key global markets for the firm?
Also &ndash; what are the key product trends that Thong Siek Global is tapping to relate with next generation consumers?&nbsp;
In this Special, &ldquo;On the Go&rdquo; episode of Under the Radar, Money Matters&rsquo; finance presenter Chua Tian Tian headed down to Thong Siek Food Global&rsquo;s factory floor to seek some answers from Novelle Lim, CEO of Thong Siek Global and Fayy Lim, Chief Operating Officer of Thong Siek Global.

Under the Radar: (SPECIALS) All about the fishballs – what should we know about DoDo’s parent Thong Siek Global and its internationalisation moves? We head down to its factory floor to find out.

It is back to the real estate sector today as we take you through the ins and outs of a real estate management services group that recently spun off its coliving arm on the Singapore Exchange. 

You might have guessed it by now. Yes we are talking about the majority shareholder of coliving brand Coliwoo, or the SGX mainboard listed LHN Group. Established in 1991, LHN Group prides itself with the ability to generate value for space owners and users alike with its expertise in Space Optimisation. 

The firm engages in four types of business operations, namely (1) space optimisation, where it redesigns unused, old and under-utilised spaces to maximise leasable area, (2) property development and investment where it engages in the acquisition, development and sale of properties, (3) facilities management including the provision of car park and energy management services, and finally (4) energy solutions, including the provision of charging stations for electric vehicles.

LHN had in November posted a net profit of S$5.9 million for the half-year ended September 2025. The performance marks an 82.7 per cent decrease from levels seen in the previous year, on the back of fair value losses on its investment properties. Revenue for the same period, though fell by a more modest 8.4 per cent on the year to S$60.9 million.

So how does the firm assess its latest performance and what will be the key drivers of growth going forward? 

Meanwhile, the firm’s coliving subsidiary Coliwoo went public on the Singapore Exchange in November 2025. The move was said to help LHN better allocate resources within the remaining businesses within the group. So how far are we seeing that play out? 

Speaking of resource allocation, LHN Group appears to be doubling down on its space optimisation business through its storage solutions subsidiary Work+Store. So how important will Work+Store be to the firm post-listing of Coliwoo?

On Under the Radar, Money Matters’ finance presenter Chua Tian Tian posed these questions to Kelvin Lim, Executive Chairman and Executive Director of LHN Group and Danny Wong, Chief Executive Officer of Work+Store. 

It is back to the real estate sector today as we take you through the ins and outs of a real estate management services group that recently spun off its coliving arm on the Singapore Exchange.&nbsp;
You might have guessed it by now. Yes we are talking about the majority shareholder of coliving brand Coliwoo, or the SGX mainboard listed LHN Group. Established in 1991, LHN Group prides itself with the ability to generate value for space owners and users alike with its expertise in Space Optimisation.&nbsp;
The firm engages in four types of business operations, namely (1) space optimisation, where it redesigns unused, old and under-utilised spaces to maximise leasable area, (2) property development and investment where it engages in the acquisition, development and sale of properties, (3) facilities management including the provision of car park and energy management services, and finally (4) energy solutions, including the provision of charging stations for electric vehicles.
LHN had in November posted a net profit of S$5.9 million for the half-year ended September 2025. The performance marks an 82.7 per cent decrease from levels seen in the previous year, on the back of fair value losses on its investment properties. Revenue for the same period, though fell by a more modest 8.4 per cent on the year to S$60.9 million.
So how does the firm assess its latest performance and what will be the key drivers of growth going forward?&nbsp;
Meanwhile, the firm&rsquo;s coliving subsidiary Coliwoo went public on the Singapore Exchange in November 2025. The move was said to help LHN better allocate resources within the remaining businesses within the group. So how far are we seeing that play out?&nbsp;
Speaking of resource allocation, LHN Group appears to be doubling down on its space optimisation business through its storage solutions subsidiary Work+Store. So how important will Work+Store be to the firm post-listing of Coliwoo?
On Under the Radar, Money Matters&rsquo; finance presenter Chua Tian Tian posed these questions to Kelvin Lim, Executive Chairman and Executive Director of LHN Group and Danny Wong, Chief Executive Officer of Work+Store.&nbsp;

Under the Radar: What should we know about Italian pharmaceutical giant Menarini’s growth story in APAC and how important are partnerships to the firm?

In 3 playlist(s)

Under The Radar

Social links

Follow podcast

Recent clips